Morgan Stanley maintains MetLife at 'overweight' with a price target of $78.00

An analyst from Morgan Stanley maintained MetLife (NYSE: MET ) at 'overweight' with a price target of $78.00 from a prior price target of %currency%%price%.
Prior to this rating, MetLife had 11 buy ratings, 5 hold ratings, and 0 sell ratings.
For consensus analyst estimates and price targets on MetLife, click here. For more news on MetLife, click here.
MetLife's stock price closed at $50.38. They are down -7.83% in the last month and down -23.89% in the last 12 months.
According to Investing Pro, MetLife's fair value is $54.24, an upside of 7.66%. MetLife's fair value comes with a medium degree of uncertainty, according to InvestingPro.
Check out MetLife's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or